CLINICAL_TRIALS
trial_result
· 2011-08-31
Clinical Trial Update: Intraocular Pressure (IOP) Lowering Efficacy of Transdermal Latanoprost Therapy [Phase 2]
Summary
A Phase 2 trial update evaluating whether transdermal latanoprost lowers intraocular pressure in glaucoma patients.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Nanduri, Padma, M.D., FACS | Conditions: Glaucoma | Phase 2 | Status: UNKNOWN